View Pages
Stock Movers: SK Hynix Drops, Biogen Up on Alzheimer’s Data Hopes, TriCo Rises
Market movers: SK Hynix plunges amid Korea AI selloff; Biogen upgraded ahead of Alzheimer’s data; TriCo rises on $63.12-per-share First Hawaiian acquisition announcement.
Editorial companion
What stands out
An AI-fueled rout in South Korea knocked SK Hynix down and sent shockwaves into U.S. trading, but the episode spends real time on Biogen after a Truist upgrade ahead of pivotal Alzheimer's data for diranersen at the Alzheimer's Association International Conference in London. That upgrade is the kind of short, sharp market event that can concentrate attention and capital into a single binary moment. For disciplined investors, this clip is a reminder that clinical readouts still move biotech stock prices more than quarterly sales do.